Change of Name

Recorded: 2017-08-22 Pages: 14

Assignor

NOVOZYMES BIOPHARMA DK A/S

Executed: 2017-04-21

Assignee

ALBUMEDIX A/S

LOTTENBORGVEJ 26, LYNGBY, DK-2800, DENMARK

Covered Property (1)

Treatment with Factor Vii-Albumin Fusion Protein

Patent: 9,849,162 →

Application: 13/855,454 →

Publication: US 2014/0004095

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.